Welcome to the State of California 

MDL logo

Test Order

Neisseria meningitidis

Pre-Approval Required


Supplemental Information or Form

1.    Pure, viable subculture  of an isolate from a sterile body source

2.    Completed submittal form with 2 patient identifiers (e.g. name and date of birth), collection date and source, a brief but complete patient history, cultural history and submitting laboratory’s findings

3.  Documentation that indicates the role of this isolate in clinical disease

4.  LAB446 (11/07) (MDL-N-11)

Performed on Specimens from


Acceptable Sample/Specimen Type for Testing

Confirmed or suspected Neisseria meningitidis isolate

Minimum Volume Required


Storage & Preservation of Specimen Prior to Shipping


Transport Medium

Tubed agar medium with a secure screw cap, labeled with patient’s name

Specimen Labeling


Shipping Instructions which Include Specimen Handling Requirements

1.    Grow isolate under appropriate conditions prior to shipping.

2.    Ship at ambient temperature using appropriate DOT/IATA approved shipping procedures.

Test Methodology

As needed - Biochemical testing, Serogrouping by slide agglutination or, if appropriate, by an in-house validated PCR procedure, Gene Sequencing by PCR, and/ or MALDI-TOF mass spectrometry. Please note that serogrouping will only be performed on isolates from sterile body sites, such as blood or cerebrospinal fluid, that have been confirmed as Neisseria meningitidis.

Turnaround Time

1 week

Interferences & Limitations

Mixed or nonviable culture

Additional Information

Please contact the MDL Vaccine Preventable Pathogens Unit for special consideration if any of the above criteria cannot be met.

MDL Points of Contact

Vaccine Preventable Pathogens Unit (510) 412-3700

Monday-Friday 8 AM to 5 PM PT

Emails: jennifer.kyle@cdph.ca.gov, fengfeng.xu@cdph.ca.gov or margot.graves@cdph.ca.gov

Last modified on: 1/7/2015 1:49 PM